Biovail Axes U.S. Commercial Organization, Seeks Promotional Partner For Zovirax
This article was originally published in The Pink Sheet Daily
Executive Summary
With the potential entry of generic Wellbutrin XL looming, Biovail cuts 200-person commercial organization in the U.S.